The study is a double-blind, placebo-controlled study of forty female participants, aged
thirty to fifty-five years, conducted over a period of ninety days.The research sample will
be shared by another Homoeopathy Master's student Fayrooz Karriem who is researching "The
efficacy of the combination of Red Vine extract, Butcher's Broom, Horse Chestnut and Vitamin
B6 in the treatment of chronic venous insufficiency associated symptoms. Participants will be
recruited by means of advertisements at the University of Johannesburg (UJ) Health Clinics.
The research sample will be randomly divided into two groups (X and Y), in matched pairs
according to age and severity of symptoms. Participants will select a remedy from one of the
boxes, marked with X or Y, thereby allocating themselves to either the experimental group or
the control group.
At the first consultation, respondents will undergo a screening test for eligibility to
participate in the study. This will be done by means of the inclusion and exclusion criteria.
Participants that are eligible to take part in the study will be given an information and
consent form to read and sign. If any questions arise, they will be answered by the
researcher. A physical examination will be conducted using a modified University of
Johannesburg Homoeopathy case taking form. The physical examination will include vital signs
and examination procedure for CVI. Participants will be asked to fill in the CIVIQ-20
questionnaire with the assistance of the researcher.
At the end of the first consultation participants will be given either the combination of Red
Vine, Butcher's Broom, Horse Chestnut and Vitamin B6 capsules or placebo capsules and will be
advised to start taking the capsules the next morning. Participants will be given enough
capsules to last them until the next consultation (30 capsules); participants will also be
advised not to change their normal routine during the course of the study. If it happens that
the participants take aspirin during the course of the study, they will be required to report
it to the researcher. Aspirin has anti-coagulant effects which may have an effect on CVI.
On day thirty of the study, participants will have the first follow up consultation. A
physical examination will be conducted and participants will fill out the CIVIQ-20
questionnaire based on their experience over the past thirty days. At the end of the first
follow up, participants will be given thirty capsules of the herbal combination or placebo
(as selected by the participant after the first consultation) to be taken as previously
instructed.
On day sixty a second follow up consultation will be conducted and the procedure followed on
day thirty will be repeated on day sixty.
The final follow up consultation will be on day ninety, where a physical examination will be
conducted and the CIVIQ-20 questionnaire will be completed. On the last day no capsules will
be given.
All data collected by the questionnaire, will be statistically analysed with the assistance
of a statistician at Statkon, UJ. The between groups comparison will be analysed using the
Mann-Whitney U-test. The comparison within the groups will be conducted using the Friedman
test and differences over time will be analysed using the Wilcoxon post hoc test.